• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    Galectin Therapeutics, Inc. (GALT)

    -NasdaqCM
    1.17 Down 0.03(2.50%) Feb 5, 3:58PM EST
    Prev Close:1.20
    Open:1.20
    Bid:1.15 x 100
    Ask:1.95 x 3000
    1y Target Est:9.50
    Beta:1.45978
    Earnings Date:Mar 16 - Mar 21 (Est.)
    Day's Range:1.17 - 1.25
    52wk Range:1.17 - 4.40
    Volume:76,657
    Avg Vol (3m):138,597
    Market Cap:33.60M
    P/E (ttm):N/A
    EPS (ttm):-0.87
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for GALT

    Comparison

    Symbol% ChgMkt Cap
    GALTDown 2.50%33.60M
    MNTADown 5.23%810.70M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.84
    Quarterly EPS Est (Dec-15) :-0.21
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic disease and cancer. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback